The RNA-binding protein SUP-12 controls muscle-specific splicing of the ADF/cofilin pre-mRNA in C. elegans by Anyanful, Akwasi et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 167, No. 4, November 22, 2004 639–647
http://www.jcb.org/cgi/doi/10.1083/jcb.200407085
 
JCB: ARTICLE
 
JCB 639
 
The RNA-binding protein SUP-12 controls muscle-
speciﬁc splicing of the ADF/coﬁlin pre-mRNA 
in 
 
C. elegans
 
Akwasi Anyanful,
 
1
 
 Kanako Ono,
 
1
 
 Robert C. Johnsen,
 
2
 
 Hinh Ly,
 
1
 
 Victor Jensen,
 
2
 
 David L. Baillie,
 
2
 
 and Shoichiro Ono
 
1
 
1
 
Department of Pathology, Emory University, Atlanta, GA 30322
 
2
 
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6
 
issue-speciﬁc alternative pre-mRNA splicing is essen-
tial for increasing diversity of functionally different
gene products. In 
 
Caenorhabditis elegans
 
, UNC-
60A and UNC-60B, nonmuscle and muscle isoforms of
actin depolymerizing factor (ADF)/coﬁlin, are expressed
by alternative splicing of 
 
unc-60
 
 and regulate distinct
actin-dependent developmental processes. We report that
SUP-12, a member of a new family of RNA recognition
motif (RRM) proteins, including SEB-4, regulates muscle-
speciﬁc splicing of 
 
unc-60
 
. In 
 
sup-12
 
 mutants, expression of
UNC-60B is decreased, whereas UNC-60A is up-regulated
T
 
in muscle. 
 
sup-12
 
 mutations strongly suppress muscle
defects in 
 
unc-60B
 
 mutants by allowing expression of
UNC-60A in muscle that can substitute for UNC-60B, thus
unmasking their functional redundancy. SUP-12 is ex-
pressed in muscle and localized to the nuclei in a speckled
pattern. The RRM domain of SUP-12 binds to several sites
of the 
 
unc-60
 
 pre-mRNA including the UG repeats near
the 3
 
 
 
-splice site in the ﬁrst intron. Our results suggest that
SUP-12 is a novel tissue-speciﬁc splicing factor and regu-
lates functional redundancy among ADF/coﬁlin isoforms.
 
Introduction
 
Pre-messenger RNA splicing is mediated by spliceosomes that
contain small ribonucleoprotein particles and splicing factors
(Jurica and Moore, 2003; Nilsen, 2003). Pre-mRNAs are of-
ten alternatively spliced to give rise to multiple mRNA spe-
cies, which requires additional regulation of splice-site selection
(Smith and Valcarcel, 2000; Maniatis and Tasic, 2002; Black,
2003). Tissue-specific alternative mRNA splicing is essential for
expression of functionally different gene products from a single
gene, and, thus, it is an important mechanism of cellular differ-
entiation. Disruption of the splicing machinery is known to
cause various human diseases (Nissim-Rafinia and Kerem, 2002;
Stoilov et al., 2002; Faustino and Cooper, 2003). In particular,
myotonic dystrophy has been linked to perturbation of the mech-
anism of alternative splicing in muscle (Kanadia et al., 2003;
Ho et al., 2004). However, the molecular mechanism by which
tissue-specific alternative splicing is regulated remains largely
unknown, except for a few well-characterized examples (Smith
and Valcarcel, 2000; Maniatis and Tasic, 2002; Black, 2003).
Actin depolymerizing factor (ADF)/cofilin proteins
enhance actin filament dynamics by severing filaments and
accelerating monomer dissociation from the pointed ends of
the filaments (Bamburg, 1999; Bamburg et al., 1999; Maciver
and Hussey, 2002; Ono, 2003). Essential functions of ADF/
cofilin in in vivo actin dynamics and cell viability have been
demonstrated in several organisms (McKim et al., 1994; Gunsalus
et al., 1995; Lappalainen and Drubin, 1997). In mammals, three
ADF/cofilin isoforms are encoded by separate genes and ex-
pressed in different patterns of tissue distribution (Matsuzaki et
al., 1988; Moriyama et al., 1990; Ono et al., 1994; Gillett et al.,
1996; Thirion et al., 2001; Vartiainen et al., 2002). However,
in the nematode 
 
Caenorhabditis elegans
 
, the 
 
unc-60
 
 gene
undergoes alternative splicing and expresses two ADF/cofilin
isoforms, UNC-60A and UNC-60B (McKim et al., 1994). Our
previous studies have indicated that the two ADF/cofilin
isoforms have different activities: UNC-60A strongly depoly-
merizes filaments, whereas UNC-60B binds to filaments with
only weak depolymerizing activity (Ono and Benian, 1998;
Ono, 1999; Mohri and Ono, 2003). More importantly, they are
expressed in different tissues and required for specific actin-
dependent processes: UNC-60A is expressed in nonmuscle
cells and is required for embryonic cytokinesis (Ono et al.,
2003), whereas UNC-60B is specifically expressed in the body
wall muscle and regulates myofibril assembly (Ono et al.,
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1999). The 
 
unc-60
 
 gene has nine exons and only the first
exon is shared by unc-60A and unc-60B (McKim et al.,
1994). Therefore, the tissue-specific expression of unc-60A
or unc-60B is proposed to be determined by selection of the
first splice acceptor site at the 5
 
 
 
-end of either exon 2A or
2B (McKim et al., 1994). However, the regulatory mecha-
nism of tissue-specific splicing of the 
 
unc-60
 
 pre-mRNA is
unknown.
In this work, we report identification and characterization
of a putative splicing factor that regulates muscle-specific
splicing of the 
 
unc-60
 
 pre-mRNA in 
 
C. elegans
 
. We cloned
SUP-12, a conserved RNA-binding protein, as a suppressor of
 
unc-60B
 
. 
 
sup-12
 
 mutations strongly suppress the muscle de-
fects of 
 
unc-60B
 
 mutants. This suppression is likely due to al-
teration in expression of the 
 
unc-60
 
 splice variants in the mus-
cle cells. SUP-12 localizes to the nuclei in body wall muscle
and its RNA-binding domain directly binds to the 
 
unc-60
 
 pre-
mRNA in vitro. Our data support that SUP-12 is a novel mem-
ber of tissue-specific regulators of alternative splicing.
 
Results
 
Identification of SUP-12 as a suppressor 
of unc-60B
 
In a previous effort to identify genes that functionally interact
with 
 
unc-60
 
, 
 
sup-12
 
 mutant alleles 
 
st89
 
 and 
 
st203
 
 were isolated
from a screen for extragenic suppressors of 
 
unc-60
 
 mutants
(G.R. Francis and R.H. Waterston, personal communication;
Waterston, 1988). 
 
sup-12
 
 mutations alone have only minor ef-
fects on motility of the worms (Fig. 1 A). However, in the 
 
unc-
60B
 
 mutant backgrounds, 
 
sup-12
 
 strongly suppressed the mo-
tility defects (Fig. 1 A). The suppression by 
 
sup-12
 
 was also
equally strong for a strong loss of function allele 
 
unc-
60B(e677)
 
 and a null allele 
 
unc-60B(su158)
 
 (Fig. 1 A), as well
as other 
 
unc-60B
 
 loss of function alleles (McKim et al., 1988),
and the motility of the 
 
unc-60B;sup-12
 
 double mutants was re-
stored nearly to the level of wild-type worms (Fig. 1 A). The
motility defects of the 
 
unc-60B
 
 mutants are caused by disorga-
nization of actin filaments in the body wall muscle (Ono et al.,
1999; Ono et al., 2003). Actin was predominantly found in the
large aggregates but not in the myofibrils (Fig. 1 B). However,
in the 
 
unc-60B;sup-12
 
 double mutants, actin was organized
into the myofibrils as well as wild type (Fig. 1 B). The 
 
sup-12
 
single mutants had no detectable phenotype in the myofibril
organization (Fig. 1 B; Francis and Waterston, 1985). 
 
sup-
12(st203)
 
 exhibited slightly stronger suppressor effect than
 
sup-12(st89)
 
 in worm motility (Fig. 1 A) and in actin organiza-
tion in muscle (unpublished data). These results suggest that
 
sup-12
 
 genetically interacts with 
 
unc-60B
 
 and regulates actin
organization in the body wall muscle.
Figure 1. Suppression of the unc-60B mutant phenotype by sup-12
mutations. (A) Worm motility was quantified as beating frequency (beats/min)
as described previously (Epstein and Thomson, 1974). Data are average  
SD (n   10). Differences between wild-type and various strains were
statistically examined by a t test. *P   0.05, **P   0.005, and ***P  
0.001. (B) Actin organization in the body wall muscle was visualized by
staining worms with tetramethylrhodamine-phalloidin. Bar, 20  m.
Figure 2. Sequence of SUP-12. (A) Domain structure of the SUP-12
protein (248 aa). Positions of the RRM domain, A/Q-rich sequence, and
mutations in sup-12 mutant alleles are shown. (B) A phylogenetic tree of
SUP-12 and SEB-4–related proteins generated by a Clustal V method. The
sequences used are human SEB-4a (HSEB-4a) (AK095016), human
SEB-4b (HSEB-4b) (AY547318), Xenopus muscle-type SEB-4 (XSEB-4)
(AF223427), Xenopus neuronal SEB-4 (XSEB-4R) (AAP42281), zebra-
fish SEB-4 (DSEB-4) (BAD12194), C. elegans SUP-12 (CeSUP-12)
(NM_076273), C. briggsae SUP-12 (CbSUP-12) (CAE68500), Arabidopsis
SEB-4a to f (AtSEB-4a to f) (NM_202440, NM_202229, NM_106296,
NM_101941, NM_124747, and NM_115334). 
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By positional cloning and identification of mutation sites,
we cloned the 
 
sup-12
 
 gene and identified it as T22B2.4 (Gen-
Bank/EMBL/DDBJ accession no. NM_076273) that is mapped
to the left arm of the X chromosome by the 
 
C. elegans
 
 Se-
quencing Consortium (1998). The SUP-12 protein (248 aa) is a
putative RNA-binding protein that has a single RNA recogni-
tion motif (RRM) domain (Shamoo et al., 1995) in its NH
 
2
 
 ter-
minus (residues 35–117) and alanine- and glutamine-rich (A/Q-
rich) sequence in its COOH terminus (26 A and 24 Q in resi-
dues 121–246; Fig. 2 A). Missense mutations G59R, G77E, and
G113E were found within the RRM domain in the 
 
sup-12
 
 mu-
tant alleles 
 
s2900
 
, 
 
st89
 
, and 
 
s2896
 
, respectively (Fig. 2 A).
 
s2901
 
 has the same mutation as 
 
st89
 
, although they were iso-
lated in different laboratories. A mutation (G to A) was found
in 
 
st203
 
 at the splice donor site in the second intron. RT-PCR
analysis showed that aberrantly spliced 
 
sup-12
 
 mRNA was pre-
dominantly expressed in the 
 
sup-12(st203)
 
 mutants (unpub-
lished data). RNA interference of 
 
sup-12
 
 phenocopied the
suppressor phenotype of 
 
sup-12
 
 mutants and suppressed the
Unc-60B phenotype of multiple 
 
unc-60B
 
 alleles (unpublished
data). Homology searches revealed that SUP-12 is an ortho-
logue of a human protein SEB-4 (Fig. 2 B). Two human SEB-4
isoforms (GenBank/EMBL/DDBJ accession no. AK095016
and NM_153020) are found in the database, but their function
is unknown. In 
 
Xenopus
 
, two SEB-4 isoforms, XSEB-4 and
XSEB-4R, are reported: XSEB-4 is expressed in muscle pre-
cursor cells (Fetka et al., 2000), whereas XSEB-4R is strongly
expressed in neuronal cells and involved in neural differentia-
tion (Boy et al., 2004). Interestingly, 
 
Arabidopsis
 
 has at least six
SEB-4 orthologues (Fig. 2 B), but functional studies on these
proteins are not reported. However, no SEB-4 orthologues were
found in yeasts and 
 
Drosophila
 
. Sequence alignment of these
proteins showed highly conserved sequences in the RRM do-
main in the NH
 
2
 
 termini (unpublished data). The COOH-termi-
nal halves are not highly conserved, yet the A/Q-rich sequences
are present in all these proteins. The similarity in the sequences
suggests that SUP-12 and SEB-4 homologues belong to a new
family of functionally conserved RNA-binding proteins.
 
SUP-12 alters expression patterns of 
the 
 
unc-60
 
 splice variants
 
To understand the mechanism of suppression of the Unc-60
mutant phenotype by 
 
sup-12
 
, expression patterns of the splice
variants of the 
 
unc-60
 
 gene products were examined. Surpris-
ingly, the protein level of UNC-60B, the muscle-specific iso-
form, was greatly reduced in the 
 
sup-12
 
 mutants both in wild-
type and 
 
unc-60B(e677)
 
 backgrounds (Fig. 3 B, lanes 1–6). In
contrast, the total level of UNC-60A, the nonmuscle isoform,
was not significantly altered by mutations in 
 
sup-12
 
 or 
 
unc-60B
 
(Fig. 3 B). Similar changes were detected at the mRNA levels:
the unc-60B mRNA was reduced as compared with wild type,
whereas the unc-60A mRNA was not significantly altered (Fig.
3 C). In wild-type background, the unc-60B mRNA was de-
creased in the 
 
sup-12
 
 mutants (Fig. 3 C, lanes 1–3). 
 
unc-
60B(e677)
 
 has a missense mutation (Ono et al., 1999) and had
a greatly reduced level of the unc-60B mRNA (Fig. 3 C, lanes
4–6), which correlates with the reduced protein level (Fig. 3 B,
lane 4). 
 
unc-60B(su158)
 
 has a 600-bp deletion in the 
 
unc-60B
 
region without affecting 
 
unc-60A
 
 (Ono et al., 2003) and ex-
pressed a shorter unc-60B mRNA (Fig. 3 C, lane 7) that is not
translated into a protein (Fig. 3 B, lane 7). Nonetheless, its
mRNA level was still reduced in the 
 
sup-12
 
 mutants (Fig. 3 C,
lanes 8 and 9), strongly suggesting that SUP-12 affects the lev-
els of the unc-60B mRNA, but not directly of the protein.
Figure 3. Altered expression of UNC-60B in
the sup-12 mutants. (A) Exon-intron structure
of the unc-60 gene (McKim et al., 1994).
Boxes represent exons. Protein-coding regions
are shown in black. (B) Western blot analysis
of the protein levels of UNC-60A, UNC-60B,
and SUP-12 in the total worm lysates (20  g
protein). Levels of actin and  -tubulin show
nearly equal loading of the proteins. (C)
Northern blot analysis of the mRNA levels of
unc-60A and unc-60B in the total RNA prepa-
rations (10  g RNA). Levels of actin (act-1)
show nearly equal loading of the RNAs. 
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UNC-60A is expressed in a variety of nonmuscle cells
(Ono et al., 2003). Therefore, changes in the level of UNC-60A
in a subset of tissues may not be detected by the Northern blot
analysis. Therefore, we examined the tissue distribution of
UNC-60A by immunofluorescence microscopy and found that
the level of UNC-60A in body wall muscle is altered by sup-
12. In wild type and the unc-60B(e677) single mutant, UNC-
60A was not detectable in body wall muscle (Fig. 4, A–F, ar-
rows). However, in the unc-60B;sup-12 double mutant and the
sup-12 single mutant, UNC-60A protein was detected in the
diffuse cytoplasm (Fig. 4, G–L, arrows). These results indicate
that the sup-12 mutations have opposite effects on the levels of
the two splice variants, unc-60A and unc-60B, in muscle cells.
Although UNC-60A and UNC-60B have quantitatively differ-
ent biochemical activities, both isoforms can enhance actin fil-
ament dynamics by depolymerizing actin filaments (Ono and
Benian, 1998; Ono, 1999; Ono et al., 1999). Thus, the suppres-
sion of the Unc-60 phenotype by sup-12 could be explained by
the up-regulation of UNC-60A in muscle, which may compen-
sate for the function of UNC-60B.
SUP-12 is expressed in body wall muscle 
and localizes to the nuclei
We next investigated expression and subcellular localization of
SUP-12. An anti–SUP-12 antibody against its COOH terminus
specifically recognized the SUP-12 protein by Western blot but
did not detect the protein by immunofluorescence microscopy
(unpublished data). The 3.1-kb promoter region of the sup-12
gene was able to drive expression of a reporter GFP in body
wall muscle (Fig. 5 A, arrowheads) and pharynx (Fig. 5 A, as-
terisk). GFP-tagged SUP-12, which was expressed in the body
wall muscle under the control of the myo-3 promoter (Okkema
et al., 1993), predominantly localized to the nuclei (Fig. 5,
B–D). Within the nuclei, GFP-SUP-12 was found in diffuse and
often speckled patterns in the nucleoplasm but excluded from
the globular region, possibly representing the nucleolus (Fig. 5
B). The speckled localization of SUP-12 in the nucleus is simi-
lar to patterns that are commonly observed for other splicing
factors (Misteli, 2000; Dundr and Misteli, 2001; Lamond and
Spector, 2003). Although the myo-3 promoter is active in the
body wall muscle but not in the pharynx, myo-3–driven expres-
sion of GFP-SUP-12 was sufficient to rescue the Sup-12 mu-
tant phenotype (Table I), indicating that GFP-SUP-12 is func-
tional and expression of SUP-12 in the body wall muscle is
functionally important for its interaction with unc-60. These re-
sults strongly suggest that SUP-12 is a muscle-specific regula-
tor of pre-mRNA splicing in the nucleus.
Neither the NH2-terminal RRM domain nor the COOH-
terminal A/Q-rich domain alone was able to rescue the sup-12
mutant phenotype (Table I). The RRM domain of SUP-12 (res-
idues 1–117) localized to both nuclei and cytoplasm in a dif-
fuse pattern (Fig. 5 E), whereas the A/Q-rich domain of SUP-12
(residues 118–248) strongly localized to the nuclei in a similar
speckled pattern to the full-length protein and weakly to the cy-
toplasm (Fig. 5 F). These results suggest that either the RRM or
the A/Q-rich domain is sufficient for nuclear localization, but
both domains are required for the function of SUP-12.
Direct binding of SUP-12 to the unc-60 
pre-mRNA
To determine whether the SUP-12 protein may be directly in-
volved in pre-mRNA splicing of unc-60, we examined direct in-
teraction between SUP-12 and unc-60 pre-mRNA in vitro by an
electophoretic mobility shift assay (EMSA). Recombinant GST-
tagged full-length SUP-12 protein or the COOH-terminal por-
tion (residues 118–248) of SUP-12 were poorly soluble (unpub-
lished data) and therefore were not examined. However, the
NH2-terminal portion (residues 1–117) of SUP-12 containing
the RRM domain was stable and soluble as a GST-fusion pro-
tein. When purified GST-SUP-12 (RRM) was incubated with
various portions of in vitro transcribed unc-60 pre-mRNA (Fig.
6 A), it caused a band shift of only the 978-nt RNA fragment
that encompasses the sequence of exon 1 to a portion of exon 5A
(Fig. 6, A and B). GST alone did not cause a band shift of the
RNAs (Fig. 6 B). These results indicate that the RRM domain of
SUP-12 is sufficient for direct RNA-binding and so could confer
specificity for the 5 -region of the unc-60 pre-mRNA.
The SUP-12 binding region in the unc-60 pre-mRNA
was further narrowed down by a pull-down assay with biotin-
labeled RNA fragments (Fig. 6, C–G). We first tested interac-
Figure 4. Altered expression of UNC-60A in the body wall muscle of the
sup-12 mutants. Wild-type (A–C), unc-60B(e677) (D–F), sup-12(st203)
(G–I), or unc-60B(e677);sup-12(st203) (J–L) worms were stained for UNC-
60A (A, D, G, and J) and myoA, the muscle-specific myosin heavy chain
(B, E, H, and K). Merged images are shown in C, F, I, and L. MyoA is a
marker for the body wall muscle (arrows), but it is also expressed in
the myoepithelial sheath of the ovary (asterisks). UNC-60A is widely
expressed in nonmuscle tissues, but its expression in the body wall muscle
is increased in the sup-12 mutants (arrows). Bar, 20  m.
Table I. Dissection of the domains of SUP-12
Domain Residues Rescue Localization RNA-binding Solubility
Full-length 1–248 Yes Nuclei ND Insoluble
RRM 1–117 No Nuclei cytoplasm Yes Soluble
A/Q-rich 118–248 No Nuclei cytoplasm ND InsolubleA NOVEL MUSCLE-SPECIFIC SPLICING FACTOR • ANYANFUL ET AL. 643
tions between GST-SUP-12 (RRM) and four RNA fragments,
A1-1, A1-2, A1-3, and A1-4, within the unc-60A region (Fig. 6
C). GST-SUP-12 (RRM) bound to the magnetic beads in the
presence of A1-1 or A1-2 (Fig. 6 E, lanes 2–5). However, in
the presence of A1-3 or A1-4 (Fig. 6 E, lanes 6–9), the amounts
of captured GST-SUP-12 (RRM) were not significantly differ-
ent from that in the absence of RNA (Fig. 6 E, lane 1). GST
alone did not bind to the beads in the presence or absence of
RNA (Fig. 6 E), indicating that the RRM domain of SUP-12
mediated the interactions with RNAs.
We then used shorter RNA fragments of 10–152 bases in
the pull-down assay with GST-SUP-12 (RRM) (Fig. 6, C and
D) and characterized the interactions in a quantitative manner
(Fig. 6, F and G). GST-SUP-12 (RRM) showed relatively
strong binding with exon 1 (A1-1-1), the first intron (A1-1-2),
and the second intron (A1-2-2) but did not significantly interact
with exon 2A (A1-2-1; Fig. 6 F). Interestingly, an 18-nt trunca-
tion of A1-1-2 at the 3 -end (A1-1-2- UG; Fig. 6, C and D)
weakened the interaction with GST-SUP-12 (RRM; Fig. 6, F
and G). The truncated region contains repeats of UG that have
been reported to bind to several RNA-binding proteins (Mittag,
1996; Takahashi et al., 2000; Buratti et al., 2004). The RNA
oligonucleotide UG (5 -UGUGUGCCUG-3 ) strongly inter-
acted with GST-SUP-12 (RRM; Fig. 6 E), whereas the oligo-
nucleotide UC (5 -UCUCUCCCUC-3 ) showed nearly insig-
nificant interaction (Fig. 6 E). Densitometric quantification of
the results in Fig. 6 E indicates that only UG exhibited strong
saturable binding with GST-SUP-12 (RRM; Fig. 6 F). Binding
of GST-SUP-12 (RRM) to UG was saturated at a molar ratio of
1.1:1.0 with a dissociation constant of 0.31  M, suggesting
that they form a stoichiometric 1:1 complex with physiologi-
cally strong affinity. Removal of the UG repeats from A1-1-2
did not completely abolish the interaction of GST-SUP-12
(RRM) with A1-1-2- UG (Fig. 6, F and G), suggesting that the
UG repeats are sufficient but not necessary for this interaction.
Binding of GST-SUP-12 (RRM) to A1-1-1, A1-1-2, or A1-2-2
did not reach saturation within the conditions used in this work
(Fig. 6 G), so we were not able to determine stoichiometry and
affinity. These results demonstrate that the RRM domain of
SUP-12 directly interacts with the unc-60 pre-mRNA at multi-
ple sites within exon 1 and the first and second introns. In par-
ticular, strong interaction of the SUP-12 RRM domain with
the UG repeats near the 3 -splice site in the first intron sup-
ports that SUP-12 may function as a regulator of pre-mRNA
splicing.
Discussion
In this work, we identified SUP-12 as a critical regulator of the
muscle-specific pre-mRNA splicing of unc-60. sup-12 muta-
tions suppressed muscle-specific defects in actin organization
which was caused by unc-60B mutations. This suppression in-
volved switching of the unc-60 isoforms in the muscle cells:
sup-12 mutations enhanced muscle expression of UNC-60A,
the nonmuscle ADF/cofilin isoforms, but reduced expression
of UNC-60B, the muscle isoforms, thus allowing UNC-60A to
compensate for the function of UNC-60B in the muscle cells.
SUP-12 localized to the muscle nuclei and bound directly to
exon 1 and the first and second introns of the unc-60 pre-
mRNA in vitro, suggesting that SUP-12 is directly involved in
muscle-specific splicing of the unc-60 pre-mRNA.
Our data indicate that, in muscle cells, SUP-12 normally
inhibits production of the unc-60A mRNA, but it enhances ex-
pression of the unc-60B mRNA. Several possibilities for the
Figure 5. Expression and subcellular local-
ization of SUP-12. (A) A 3.1-kb promoter region
of sup-12 drove expression of the GFP reporter
in the body wall muscle (arrowheads). The
promoter activity was also strong in the phar-
ynx (asterisk). A representative L3 larva ex-
pressing GFP is shown. Bar, 20  m. (B–D)
Nuclear localization of the GFP-SUP-12 fusion
protein driven by the body wall muscle-specific
myo-3 promoter. Staining of nuclei by DAPI
(C) revealed colocalization of some of the
muscle nuclei (arrows) with GFP-SUP-12 (D).
(E and F) Localization of GFP-SUP-12 (1–117)
(RRM domain) (E) or GFP-SUP-12 (118–248)
(A/Q-rich) (F). Bar, 10  m.JCB • VOLUME 167 • NUMBER 4 • 2004 644
mechanism by which SUP-12 regulates expression of unc-60A
and unc-60B could be considered. The most probable model is
that the general splicing machinery may preferentially induce
the splicing between exons 1 and 2A to produce unc-60A,
whereas SUP-12 likely acts as an inhibitor of this splicing
event. This model is strongly supported by the presence of UG
repeats near the 3 -end of the first intron, which strongly inter-
acts with the RRM domain of SUP-12. In the human cystic fi-
Figure 6. Direct interaction of the SUP-12 RRM domain with the unc-60 pre-mRNA. Interactions between the SUP-12 RRM domain and fragments of the unc-60
pre-mRNA were examined by EMSA (A and B) or a biotin-RNA pull-down assay (C–G). (A) Four synthetic RNA fragments A1, A2, B1, and B2, were transcribed
in vitro and used for EMSA with GST or GST-SUP-12 (RRM domain). (B) 
32P-labeled RNAs were incubated with buffer alone (lanes 1, 4, 7, and 10), GST (lanes
2, 5, 8, and 11), or GST-SUP-12 (RRM) (lanes 3, 6, 9, and 12) and separated by agarose-gel electrophoresis. Arrow indicates unbound RNAs. Band shift
(asterisk) was observed only in a mixture of A1 and GST-SUP-12 (RRM) (lane 3). (C) Schematic representation of RNA fragments used in the biotin-RNA pull-
down assays. (D) Sequence of the unc-60 pre-mRNA near the splice site at the 5 -end of exon 2A. Intron sequence is shown in small letters, exon sequence in
capital letters. The UG-repeat sequence used in the oligonucleotide UG is in bold. UC is a control oligonucleotide that has UC repeats instead of UG repeats. (E)
GST-SUP-12 (RRM) or GST (0.5 or 5.0  M) was incubated with a biotin-labeled RNA fragment (80 nM), and the protein–RNA complex was captured by
streptavidin-magnetic particles and analyzed by SDS-PAGE and Coomassie staining. GST-SUP-12 (RRM), but not GST, showed significant interactions with A1-1
(lanes 2 and 3) and A1-2 (lanes 4 and 5). (F) Interactions between GST-SUP-12 (RRM) at varied concentrations (0.2–5.0  M) and various RNA fragments at 0.1
 M (total 20 pmol) were examined by the biotin-RNA pull-down assay in a final volume of 200  l. Known amounts (10, 25, or 50 pmol) of GST-SUP-12 (RRM)
were applied to each gel as standards for densitometric quantification. (G) Densitometric quantification of GST-SUP-12 (RRM) that was bound to biotin-RNA.A NOVEL MUSCLE-SPECIFIC SPLICING FACTOR • ANYANFUL ET AL. 645
brosis transmembrane conductance regulator pre-mRNA, the
nuclear RRM protein TDP-43 binds to the UG repeats at the 3 -
end of intron 8 and causes exon skipping (Niksic et al., 1999;
Pagani et al., 2000; Buratti et al., 2004). Thus, SUP-12 and
TDP-43 may negatively regulate splicing in a similar manner
by binding to UG repeats and directly competing with the U2
auxiliary factor, which is an essential splicing factor that binds
to 3 -splice sites (Merendino et al., 1999; Wu et al., 1999; Zo-
rio and Blumenthal, 1999).
An alternative model is that SUP-12 may indirectly in-
hibit 3 -end processing of the unc-60A pre-mRNA. Because
the SUP-12–binding sites on the unc-60 pre-mRNA are not
close to the polyadenylation site of unc-60A, SUP-12 may have
to interact with 3 -end processing factors to influence this pro-
cess. The last exon (5A) for unc-60A that contains the 3 -
untranslated region resides upstream of exon 2B (Fig. 3 A). In
nonmuscle cells, the mRNA 3 -end processing factors may
cleave the pre-mRNA and polyadenylate after exon 5A but be-
fore exon 2B is transcribed. Therefore, in muscle cells, SUP-12
may inhibit 3 -end processing at exon 5A and promote elonga-
tion of the pre-mRNA. Indeed, in case of polycistronic genes in
C. elegans, an interaction between a 3 -end processing factor
and a factor for trans-splicing is reported (Evans et al., 2001).
Also, it is possible that SUP-12 affects RNA stability or inter-
acts with transcription factors and regulates transcription and
pre-mRNA processing because splicing factors and transcrip-
tion factors functionally interact and regulate pre-mRNA splic-
ing in many instances (Bentley, 2002). In addition, we cannot
exclude the possibility that SUP-12 may regulate relative sta-
bility of the two mRNAs.
The RRM domain of SUP-12 had activity to bind to the
5 -region of the unc-60 pre-mRNA but was unable to rescue
the sup-12 mutant phenotype. This suggests that the COOH-
terminal A/Q-rich sequence plays an important function. Al-
though the function of the A/Q-rich sequence is unknown, it is
intriguing that MEC-8, which regulates alternative splicing of
unc-52 in the hypodermis in C. elegans (Lundquist et al., 1996;
Spike et al., 2002), also contains an A/Q-rich region in addition
to two RRM domains. The A/Q-rich sequence might have a
regulatory function for a splicing factor or mediate interactions
with other splicing factors, transcription factors, or 3 -end pro-
cessing factors. We showed that the A/Q-rich region of SUP-12
is necessary and sufficient for speckled localization in the nu-
clei, suggesting that this region is important for SUP-12 to lo-
calize to speckles. Also, we noted that the bacterially expressed
full-length SUP-12 protein was not only insoluble but also very
susceptible for proteolysis (unpublished data), suggesting that
the A/Q-rich sequence may regulate protein stability.
Furthermore, this work suggests that functional redun-
dancy of the two ADF/cofilin isoforms in muscle is normally
masked by tight regulation of tissue-specific splicing by sup-
12. Thus, sup-12 mutations unmask the redundancy and allow
UNC-60A to compensate for mutated UNC-60B in unc-60B
mutants. From our previous work, it seemed logical to hypothe-
size that UNC-60B with weaker depolymerizing activity might
be more suitable in muscle cells than UNC-60A, where less dy-
namic actin reorganization is needed than nonmuscle cells.
Therefore, it is somewhat surprising that UNC-60A can substi-
tute for UNC-60B in muscle. However, it is possible that, al-
though the sup-12 mutants have apparently normal myofibrils,
their muscle may exhibit different physiological properties from
that of wild type under specific conditions. A number of human
diseases are caused by alterations in the pre-mRNA splicing
(Nissim-Rafinia and Kerem, 2002; Stoilov et al., 2002; Faustino
and Cooper, 2003). However, our results suggest that, the splic-
ing machinery is a potential therapeutic target for certain ge-
netic diseases in which manipulation of tissue-specific splicing
machinery may reveal hidden functional redundancy among
splice variants to compensate for a disease gene. We propose
that SUP-12– and SEB-4–related proteins are a new family of
tissue-specific splicing factors in multicellular organisms.
Materials and methods
Nematode strains
Wild-type N2 and unc-60B(e677) (Waterston et al., 1980) were obtained
from the Caenorhabditis Genetics Center (Minneapolis, MN). sup-12(st89)
and sup-12(st203) were obtained from G.R. Francis (Exelixis, Inc., South
San Francisco, CA) and R. Waterston (University of Washington, Seattle,
WA). sup-12(s2896), sup-12(s2900) and sup-12(s2901) were isolated by
a screen for suppressors of unc-60B. In brief, unc-60B(e677) homozygotes
were mutagenized by ethyl methanesulfonate and F2 worms with im-
proved motility were isolated. unc-60B(su158) (Zengel and Epstein, 1980)
was originally obtained from H.F. Epstein (University of Texas Medical
Branch at Galveston, Galveston, TX) and characterized previously (Ono et
al., 2003).
Cloning of sup-12
sup-12 was mapped to the left arm of the X chromosome that was in-
cluded in the duplication mnDp33 (G.R. Francis and R.H. Waterston, per-
sonal communication). We further narrowed down sup-12 by the snip-
SNP mapping with polymorphisms in CB4856 (Wicks et al., 2001) to an
interval between cosmid clones ZC64 and T06F4 that contained  20
genes. We performed feeding RNA interference of 10 genes in wild type
and unc-60B(su158) and examined for a suppressor phenotype for unc-
60B(su158). We found that T22B2.4(RNAi) suppressed the motility defect
of unc-60B(su158) but did not affect motility of wild type. To confirm that
T22B2.4 is sup-12, we sequenced the T22B2.4 gene in the sup-12 mu-
tants and identified mutations in multiple sup-12 alleles (Results and Fig.
2 A).
Fluorescence microscopy
Actin filaments were visualized by staining adult worms with tetrameth-
ylrhodamine-phalloidin (Sigma-Aldrich) as described previously (Ono,
2001). Immunofluorescent staining was performed on adult worms that
were permeabilized with a freeze-crack method (Epstein et al., 1993) and
fixed with methanol for 5 min at  20 C. Primary antibodies used were
anti–UNC-60A (Ono et al., 1999) and anti-myoA (mAb 5.6, obtained from
H.F. Epstein; Miller et al., 1983). Secondary antibodies were Alexa488-
labeled goat anti–rabbit IgG and Alexa647-labeled goat anti–mouse IgG
(Molecular Probes). To visualize nuclei, worms were fixed with 4% formal-
dehyde in PBS for 30 min at RT, permeabilized with acetone at  20 C for
5 min, and stained with DAPI (Sigma-Aldrich) at 1  g/ml in PBS containing
0.5% Triton X-100, 1 mM EDTA, and 0.05% sodium azide for 15 min.
Fluorescent samples were mounted with the ProLong antifading re-
agent (Molecular Probes) and viewed by epifluorescence using an in-
verted microscope (model Eclipse TE2000; Nikon) with a 40  CFI Plan
Fluor objective (dry; NA 1.4). Images were captured by a SPOT RT Mono-
chrome CCD camera (Diagnostic Instruments) and processed by the IPLab
imaging software (Scanalytics, Inc.) and Adobe Photoshop 6.0.
Northern and Western blots
Total nematode RNA was isolated using a TRI reagent (Sigma-Aldrich).
RNA samples (10  g) were subjected to formaldehyde-agarose gel elec-
trophoresis, transferred to positively charged nylon membranes (Milli-
pore), and fixed by ultraviolet irradiation. cDNAs for unc-60A (505 bp),
unc-60B (460 bp), and actin (act-1) (1.1 kb) were amplified by PCR, la-JCB • VOLUME 167 • NUMBER 4 • 2004 646
beled with digoxigenin with random priming, and used as probes for
Northern blotting using the DIG-High Prime DNA Labeling and Detection
Starter Kit II (Roche Applied Science). Western blot was performed as de-
scribed previously (Ono and Ono, 2002) using the following primary anti-
bodies: anti–UNC-60A (Ono et al., 1999), anti–UNC-60B (Ono et al.,
1999), anti-actin monoclonal C4 (ICN Biomedicals), and anti– -tubulin
(Amersham Biosciences).
Transgenic expression of GFP and GFP-SUP-12
To determine the promoter activity of sup-12, a 3,418-bp genomic frag-
ment containing the 3,087-bp upstream region, exon 1, intron 1, and 58-
bp of exon 2, was amplified by PCR using ExTaq DNA polymerase
(Takara) and cloned into the gfp expression vector pPD95.67 (obtained
from A. Fire, Stanford University, Stanford, CA) at the 5 -end of the gfp
coding region. For expression of GFP-SUP-12 in body wall muscle, the
sup-12 cDNA (yk1125e08, obtained from Y. Kohara, National Institute of
Genetics, Mishima, Japan) was ligated in-frame with the 3 -end of gfp in
pPD118.20 (obtained from A. Fire) that has the myo-3 promoter. For ex-
pression of fragments of SUP-12 as GFP-fusion proteins, fragments of the
sup-12 cDNA encoding residues 1–117 or 118–248 were amplified by
PCR and ligated in-frame with the 3 -end of gfp in pPD118.20. A synthetic
stop codon was added for expression of residues 1–117. The plasmids
were injected into hermaphroditic gonads of wild type or unc-60B(su158);
sup-12(st89) at 10  g/ml together with a dominant marker pRF4(rol-
6(su1006)) at 90  g/ml, and transgenic worms were selected by their
roller phenotype or expression of GFP.
Electrophoretic mobility shift assay
A cDNA fragment encoding residues 1–117 of SUP-12 and a synthetic
stop codon was amplified by PCR and cloned into the SmaI–EcoRI cloning
site of a GST expression vector pGEX-2T (Amersham Biosciences). The in-
sert was sequenced to confirm that no mutations were introduced by PCR.
GST alone or GST-SUP-12 (RRM) was expressed in Escherichia coli
BL21 (DE3) by induction with 0.1 mM IPTG for 3 h and purified with
Glutathione-Uniflow (BD Biosciences Clontech) following manufacturer’s
instruction.
Template DNA fragments used in the in vitro transcription reactions
were amplified from C. elegans genomic DNA using the primers listed in
Tables S1 and S2 (available at http://www.jcb.org/cgi/content/full/
jcb.200407085/DC1). The sense primers contain the SP6 promoter se-
quence. Each RNA was in vitro transcribed using the MAXIscript kit (Am-
bion) in the presence of 50  Ci of  -[
32P]CTP (Amersham Biosciences) and
purified with a Sephadex G-25 spin column (Amersham Biosciences).
RNAs (5   10
5 cpm) were denatured in water at 95 C for 2 min, chilled
on ice for 2 min, and incubated with either buffer, or buffer and 1  M
GST or buffer and 1  M GST-SUP-12 (RRM) for 30 min at RT. The buffer
contained 50 mM KCl, 5 mM MgCl2, 10% glycerol, 40 mM DTT, 0.1
mg/ml yeast tRNA, and 10 mM Hepes, pH 7.4). The samples were re-
solved on a 1% agarose gel in 1   TAE (40 mM Tris-acetate, 2 mM
EDTA, pH 8.3). The gels were dried and analyzed by the PhosphorImager
(Molecular Dynamics).
Biotin-RNA pull-down assay
Biotin-RNA pull-down assay (Lee and Schedl, 2001) was performed with
the following modifications. Template DNAs for in vitro transcription of
RNAs (95–284 bases) were amplified from C. elegans genomic DNA us-
ing the primers listed in Tables S1 and S2. The sense primers contain the
T7 promoter sequence. Biotin-labeled RNAs were in vitro transcribed with
T7 RNA polymerase (Invitrogen) in the presence of Biotin RNA Labeling
Mix (Roche Applied Science) at 37 C for 2 h. The template DNAs were di-
gested by RNase-free DNase I (Roche Applied Science) and the labeled
RNAs purified with SigmaSpin Post-Reaction Clean-Up Columns (Sigma-
Aldrich). RNA oligonucleotides UG (5 -UGUGUGCCUG-3 ) and UC (5 -
UCUCUCCCUC-3 ) were synthesized and chemically labeled by biotin at
the 5 -ends by Integrated DNA Technologies.
Biotin-labeled RNA at 0.1  M was incubated with GST or GST-
SUP-12 (RRM) in RP buffer (50 mM KCl, 1 mM MgCl2, 10 mM Hepes-
NaOH, pH 7.5) containing 10 mM DTT and 100  g/ml yeast tRNA
(Ambion) in a final volume of 200  l at RT for 30 min. The mixtures were
incubated with 0.1 mg of streptavidin MagneSphere Paramagnetic Parti-
cle (Promega) at RT for 20 min. The magnetic particles were isolated with
a magnetic separation stand, washed three times with RP buffer, suspended
in 20  l of SDS sample buffer (2% SDS, 80 mM Tris-HCl, 5%  -mercapto-
ethanol, 15% glycerol, 0.05% bromophenol blue, pH 6.8), and incubated
at 97 C for 2 min. Bound proteins were analyzed by SDS-PAGE (12%
acrylamide gel) and staining with Coomassie Brilliant blue R-250 (Na-
tional Diagnostics). The Coomassie-stained gels were scanned by a UMAX
PowerLook III scanner at 300 dots per inch and the band intensity was
quantified with Scion Image Beta 4.02 (Scion Corporation) by comparing
with the intensities of known amounts of GST-SUP-12 (RRM).
Online supplemental material
Table S1 contains a list of PCR primers for amplifying template DNAs for
in vitro transcription. Table S2 contains a list of primer combinations for
PCR amplification of the template DNAs. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200407085/DC1.
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